MTL Cannabis Corp C.MTLC

Alternate Symbol(s): MTLNF

Cannabis

MTL Cannabis Corp. is focused on crafting cannabis products, including lines of dried flower, pre-rolls and hash marketed. The Company, through its subsidiaries, is engaged in the cultivation and production of cannabis products for recreational and medical purposes in Canada. It also operates clinics that work directly with primary care teams to provide specialized cannabinoid therapy services to patients suffering from medical conditions. Its wholly owned subsidiaries include Montreal Medical Cannabis Inc. (Montreal Cannabis), Abba Medix Corp. (Abba), Canada House Clinics Inc. (CHC), and IsoCanMed Inc. (ICM). Montreal Medical is a licensed producer operating from a 57,000 sq ft licensed indoor growing facility in Pointe Claire, Quebec. Abba is a licensed producer in Pickering, Ontario that operates a medical cannabis marketplace. CHC is operating clinics across Canada. ICM is a licensed producer in Louiseville, Quebec growing indoor cannabis in its 64,000 sq. ft. production facility.

CSE:MTLC - Post by User

MTL Cannabis Corp > We are all done for.

<< Previous

Bullboard Posts

Next >>

Post by prestedon Sep 29, 2021 5:03pm

352 Views

Post# 33940849

We are all done for.

Financial Highlights:

Cash position was $741 as at July 31, 2021 compared to $1,835 as at April 30, 2021.
Revenue was $4,024, an increase of $1,497 or 59%, compared to $2,527 during the same period in the prior year.
Loss and Comprehensive Loss for the three months was $2,575, an increase of $1,943 or 307% compared to a loss of $632 during the same period in 2020. Loss and Comprehensive Loss for the three months ending July 31, 2021 included a one-time inventory impairment of $1,004 and there was an unrealized gain on changes in fair value of biological assets of $712 in the same period of the prior year.
Cash flow used in operating activities was $347, an increase of $69 or 25%, compared to $278 during the same period in 2020.
Cash flow used in investing activities was $576 during the three months ending July 31, 2021, $131 of net cash was provided by the investing activities during the same period in the prior year.
Net cash used in financing activities was $171 compared to $268 during the same period in 2020.
Shareholder's equity was a surplus of $4,484 compared to $6,873 as of April 30, 2021.